Ming S. Tsao
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 139 publications
Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.
Journal: Frontiers in oncology
Published: May 09, 2026
Panel of Methylation-based PCRs for Separating Mucinous Lung Adenocarcinomas from Gastrointestinal Metastases Involving the Lung.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 12, 2026
Evaluating eight smoking metrics for modelling survival in non-small cell lung cancer.
Journal: Cancer epidemiology
Published: December 09, 2025
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Impact of Common Molecular Alterations and PD-L1 Expression on Overall Survival in a Select Cohort from the IASLC 9th Edition Staging Database.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 03, 2025
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Impact of Common Molecular Alterations and Programmed Death-Ligand 1 Expression on Overall Survival in a Select Cohort From the International Association for the Study of Lung Cancer Ninth Edition Staging Database.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 03, 2025
Corrigendum to "The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database. [Journal of Thoracic Oncology Vol. 20 No. 10: 1423-1440]".
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 01, 2025
Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and Strategies.
Journal: JTO clinical and research reports
Published: September 09, 2025
Biomarker Testing Among Patients With Nonsquamous NSCLC Across Three Time Periods and Three Testing Platforms-A Brief Report.
Journal: JTO clinical and research reports
Published: August 15, 2025
MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancer.
Journal: NPJ precision oncology
Published: June 10, 2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastases.
Journal: Therapeutic advances in medical oncology
Published: May 12, 2025
Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 24, 2025
Double vulnerability of active-NRF2 lung squamous cell carcinoma to NRF2 and TRIM24.
Journal: Molecular cancer
Published: March 31, 2025
Last Updated: 09/26/2026